Navigation Links
The flip side of AIDS cocktails – HAART regime damages live

HIV infected patients on highly active antiretroviral therapy (HAART regime) are forced to stop the treatment because of the toxic side effects of the treatment, which causes liver damage. According to a study led by Dr. Raymond T. Chung, who presented the findings at Digestive Disease Week in Atlanta last week, severe liver toxicity forced almost one in every four patients to stop the treatment.

Regimens that contained drugs called nonnucleoside reverse transcriptase inhibitors, especially nevirapine and efavirenz, were particularly hard on the liver, Chung and colleagues found. In more than 25% of the cases the HAART regime cost elevation of liver enzymes to more than five times the upper limit of normal resulting in severe liver toxicity.

The drug cocktails have however clearly improved the condition of the patient in terms of controlling the HIV disease but the side effects on liver forced many to stop treatment. Dr. Chung said the next step would be to see if there are factors that may help doctors predict which HIV infected patients are most at risk for severe liver toxicity with HAART. The idea would be to single out those patients who require close monitoring.


'"/>




Page: 1

Related medicine news :

1. Need for considering cardiovascular risks before giving HAART for HIV/aids patients
2. Combination regime may work against prostate cancer
3. Hormone regimen and how recently used may determine cancer risk
4. Cardiac events better treated with intense cholesterol-lowering regime
5. Simplest therapeutic regimen found less effective against HIV
6. Protective regimen for acute Graft-versus-host disease
7. Diet & Exercise regime Not Harmful For Overweight, Lactating Mothers Or their Infants
8. Food packaging with Bisphenol A damages the brain
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/21/2017)... Yorba Linda, Ca (PRWEB) , ... August 22, ... ... for numerous industries, but not without risk to health and safety. By learning ... risks could be eliminated. , In this webinar, attendees will gain a ...
(Date:8/21/2017)... ... August 21, 2017 , ... Five chefs from local senior assisted living homes ... , Guests will be able to vote for their favorite Chef among the ... Fennel Dill Salad, Feta Cheese Sauce & Garlic Pita Crisp, Greek Mountain Ice Tea ...
(Date:8/21/2017)... ... August 21, 2017 , ... The American Hospital Association (AHA) has ... Highmark Health company, to its Board of Trustees for a three-year term beginning January ... care provider organizations and individuals that are committed to the improvement of health in ...
(Date:8/20/2017)... Land Texas (PRWEB) , ... August 20, 2017 ... ... announce that the HIPAA ComplyPAK™ Compliance Management System has assisted multiple ... Institute of Certified Public Accountants, Service Organization Control Level 2 (AICPA SOC Level ...
(Date:8/19/2017)... California (PRWEB) , ... August 18, 2017 , ... ... a partnership aimed at creating a transparent, verifiable database to help the cannabis ... distributed ledger technology, Paragon hopes to deliver a faster technology with lower fees. ...
Breaking Medicine News(10 mins):
(Date:8/4/2017)... , Aug. 3, 2017  Agragen, LLC, a ... active in the biopharmaceutical, nutraceutical, and aquacultural feed ... of its lead drug candidates, AGR131.  This drug ... cytokine from the blood of patients suffering from ... inflammatory bowel disease. ...
(Date:8/2/2017)... 2017   Marshall County Hospital in Benton, Kentucky has ... of hospital-acquired infections (HAIs). The new addition, Tru-D SmartUVC , short for "total room ... pathogens such as C. diff , MRSA, MERS, Ebola and more. ... Tru-D SmartUVC ... Tru-D in action in a patient room ...
(Date:8/1/2017)... 1, 2017   CerSci Therapeutics , a non-opioid ... , has received notice from the National Institute ... Health (NIH) that it has been awarded a Direct-to-Phase ... $650,000 in 2017 with an additional $1,000,000 to follow ... Drug application of their lead non-opioid drug candidate CT-044 ...
Breaking Medicine Technology: